Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0001193125-13-258045
Filing Date
2013-06-13
Accepted
2013-06-13 17:18:57
Documents
1
Group Members
JACOB CAPITAL, L.L.C.RICHARD LEVYRNL VPC, LLCVICTORY PARK CREDIT OPPORTUNITIES INTERMEDIATE FUND, L.P.VICTORY PARK CREDIT OPPORTUNITIES, L.P.VICTORY PARK GP II, LLCVICTORY PARK GP, LLCVPC FUND II, L.P.VPC INTERMEDIATE FUND II (CAYMAN), L.P.

Document Format Files

Seq Description Document Type Size
1 SC 13D/A d553722dsc13da.htm SC 13D/A 228235
  Complete submission text file 0001193125-13-258045.txt   230099
Mailing Address 81 FULTON STREET BOONTON NJ 07005
Business Address 81 FULTON STREET BOONTON NJ 07005 973-265-1100
UNIGENE LABORATORIES INC (Subject) CIK: 0000352747 (see all company filings)

EIN.: 222328609 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-39337 | Film No.: 13912165
SIC: 2833 Medicinal Chemicals & Botanical Products

Mailing Address 227 WEST MONROE STREET, SUITE 3900 CHICAGO IL 60606
Business Address 227 WEST MONROE STREET, SUITE 3900 CHICAGO IL 60606 312-479-4947
Victory Park Capital Advisors, LLC (Filed by) CIK: 0001413834 (see all company filings)

EIN.: 208996172 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A